They can't be any more obvious about what's happening behind the scenes - the use of the terms "potential collaborators" and "commercial partners" is telling.
Sit tight.
___________________________________________
Ongoing engagement with DMD community, investors and pharmaceutical companies
The Company continued its communication and active engagement with key opinion leaders, potential collaborators, investors and commercial partners as a key operational priority. During the quarter the Company presented and participated at the following events...
Ann: Proposed issue of Securities - ANP, page-52
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.4¢ |
Change
-0.001(1.18%) |
Mkt cap ! $86.05M | |||
| Open | High | Low | Value | Volume |
| 8.5¢ | 8.6¢ | 8.3¢ | $67.87K | 801.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 204125 | 8.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.5¢ | 160814 | 5 |
View Market Depth
| Last trade - 14.19pm 13/11/2024 (20 minute delay) ? |
| PER (ASX) Chart |